The deal is moving. Clinical champions are bought in. The pilot contract is closed. Then it stalls
in IT security or the compliance review when your device is seeking full launch cadence. Sound
familiar?
As health systems build out formal AI oversight programs, procurement teams are increasingly asking device vendors a new set of questions throughout the device lifecycle: How was your model trained? Who is accountable when it drifts? How does a clinician report a problem? What
happens after deployment?
In reality, most AI/ML device vendors lack post-market surveillance infrastructure because governance gets grafted onto product or clinical roles mid-deal. We see documentation scattered across regulatory files and performance monitoring nonexistent in production. Consequently, hospitals have no clear pathway to escalate issues or validate ongoing safety and effectiveness. Alternatively, if physicians don’t trust AI/ML devices anymore, the costs and benefits cannot be justified.
It is more than just a procurement problem because it is also a regulatory requirement and a patient safety issue.When hospitals cannot deploy AI/ML devices without post-market surveillance, then vendors cannot win enterprise deals without demonstrating that surveillance infrastructure is in place before go-live.
The American Medical Association's "Governance for Augmented Intelligence" toolkit has become one of the most widely referenced frameworks that health systems use to evaluate AI vendors. Whether or not your hospital prospects are citing it by name, the expectations it codifies are showing up in procurement questionnaires, vendor assessments, and IT security reviews.
The framework asks for five things:
Model Fact Labels documenting training data, demographic gaps, and validated use cases
Clinical evidence framed around health outcomes, not just accuracy metrics
Risk documentation with context-specific mitigation strategies
Performance monitoring infrastructure accessible to hospital teams
Security and interoperability documentation for IT audit
But the AMA framework does not address the hardest part: what happens on day one of production use? How does your device perform in real-world hospital workflows? When performance drifts, who detects it first? How do clinicians report problems? Who investigates? How does the hospital demonstrate compliance with FDA post-market surveillance requirements?
Most device vendors have no answer to these questions and the gap will continue costing them deals.
This is where Rook Quality Systems and Grasp Health's Monitoring Service Offering (MSO)
come in. We bundle consulting expertise with proven surveillance tooling to deliver end-to-end
post-market oversight. Instead of building monitoring infrastructure yourself or asking hospitals
to operate it blindly, we provide the operational backbone that makes adoption possible.
Grasp Health's tooling provides the technical foundation for real-time
monitoring, data collection, and alerting. Rook Quality Systems provides the governance
consulting, risk frameworks, and operational protocols that turn that data into actionable
intelligence. Together, they close the post-market surveillance gap that is preventing hospitals
from deploying AI/ML devices with confidence.
1. Pre-Deployment Governance Documentation
Model Fact Labels and AMA Framework Alignment
Rook builds structured Model Fact Labels for each of your AI/ML products. This results in clinically rigorous summaries of training data composition, demographic representation gaps, validated use cases, and explicit out-of-scope warnings. These documents are audit-ready and procurement-facing and they answer the governance questions hospitals ask before they sign a contract.
2. Clinical Evidence Translation
From Technical Metrics to Health System Language
Hospital procurement teams think in terms of the Quintuple Aim: patient outcomes, care quality, cost, clinician experience, and health equity. Your model accuracy is important, but it is not what procurement committees prioritize. Rook translates your validation data into evidence that answers the questions hospitals actually ask., which is time to diagnosis reduction, racial equity, and workflow impact.
3. Context-Specific Risk Documentation
Beyond Regulatory Files
Risk documentation buried in your Design and Development File works for FDA review but it does not work for hospital procurement. Rook develops vendor-facing risk summaries covering failure modes specific to hospital contexts: LLM hallucinations in clinical workflows, performance degradation from EHR configuration changes, population-shift edge cases. More importantly, Rook documents concrete mitigation strategies specific enough for hospitals to incorporate into their annual training programs.
4. Real-Time Performance Monitoring with Grasp MSO
The Post-Market Surveillance Engine Hospitals Need
This is where Grasp Health's Monitoring Service Offering kicks in. The MSO provides:
Real-time performance dashboards showing model accuracy, decision drift, and safety metrics in production
Automated alerting when performance falls outside validated thresholds
Clinician-facing incident reporting workflows for flagging anomalous outputs
Audit-ready logs and reports for hospital compliance and FDA post-market surveillance
Hospitals get visibility into device performance on day one of deployment. Subsequently, they quickly have a clear escalation path when issues arise,our team knows immediately when something drifts, and regulatory compliance becomes an operational standard.
5. Ongoing Governance Operations and Incident Response
Your Operational Framework
Rook provides both documentation and ongoing governance operations. When a hospital has a question about your device, they reach out to Rook. When performance monitoring shows a potential safety signal, Rook coordinates the investigation with your team and the hospital. When an incident occurs, Rook proactively addresses the incident and handles the rest of the QMS downstream activities.
6. Security and Interoperability Architecture
IT Security Readiness
Rook translates technical specifications into vendor-ready security summaries that procurement teams need to see. Grasp Health's tooling is built with health system security requirements in mind.
EHR integration documentation.
HIPAA compliance architecture.
Data flow diagrams and a secured integration path for the MSO platform.
Deals that stall in compliance review. Procurement delays are stretching into months. Hospital legal teams are demanding post-market surveillance infrastructure that your team is not equipped to provide. These are real costs of not having governance and monitoring infrastructure in place before contract negotiation.
With Rook and Grasp Health's MSO bundle:
Procurement moves faster. Hospitals see post-market surveillance as a solved problem rather than a risk.
Compliance review becomes routine. You have audit-ready documentation and operational infrastructure before go-live.
Hospital customers have concrete accountability. Real-time monitoring proves your device is safe and effective in its specific context.
Your team stays focused on model improvement. Rook and Grasp Health handle governance, monitoring, and hospital relationships.
Regulatory defensibility increases. FDA post-market surveillance requirements become a competitive strength instead of a compliance burden.
Your AI/ML platform becomes enterprise-deployable. That is table stakes for hospital systems.
Hospital AI oversight programs are no longer hypothetical. Large health systems have formal AI governance committees. Procurement questionnaires routinely ask about post-market surveillance. The FDA is signaling increased scrutiny of AI/ML device performance in real-world use. The AMA toolkit is now standard procurement practice.
Early movers in your space will win by positioning post-market surveillance as built-in operational advantage. Rook and Grasp Health provide that infrastructure as a managed service. The vendors that close the post-market surveillance gap today will earn trust from physicians and hospital systems immediately.
If you are an AI/ML device vendor preparing for enterprise hospital outreach, or you have deals stalled in procurement or compliance review, a Rook & Grasp Health MSO partnership is worth the conversation.
Rook Quality Systems and Grasp Health have built an end-to-end post-market surveillance infrastructure specifically for AI/ML medical device companies. We close the gap that is preventing hospital adoption.
Connect with Rook Quality Systems to discuss how pairing governance consulting with Grasp Health's Monitoring Service Offering can accelerate your hospital procurement process and position post-market surveillance as a competitive advantage.